FDA Investigator Ekaterina Allen
Ekaterina Allen has inspections in 1 countries as of 13 Oct 2023. Ekaterina Allen has collaborated with a combined 1077 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
3
Last Inspection Date:
13 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Aimee Cunningham, PhD,
Amy Devlin, PhD,
Anissa M Cheung,
Anthony C Warchut,
Arie C Menachem,
Brenda P King,
Brentley S Collins,
Brently S Collins,
Burnell M Henry,
Christian D Lynch (CDL),
Christina Capacci Daniel, PhD,
Christopher Downey, PhD,
Dawn M Braswell,
Deborah M Trout,
Ellen P Madigan,
Gene D Arcy,
Gunther Bockhoudt,
Gunther Boekhoudt, PhD,
Jacqueline Mdiaz Albertini,
Jee Chung, PhD,
Joyce A Rockwell,
Julie D Bringger,
Justine M Corson,
Kara A Scheibner, PhD,
Kathleen R Jones, PhD,
Kelly R Lewis,
LCDR Debra Emerson,
Lily Y Koo,
Martha T Olone,
Maxwell Van Tassell, PhD,
Megan A Haggerty,
Mercy O Quagraine,
Michelle M Noe,
Monique C Lo,
Nailing Zhang,
Nancy T Waites,
Nicole K Trudel,
Omotunde O Osunsanmi,
Paula A Trost,
Prabhu P Raju,
Priscilla M Pastrana,
Randa Melhem, PhD,
Randy L Clarida,
Richard H Penta,
Richard W Thornton,
Robin Levis, PhD,
Sean R Marcsisin,
Seth A Mailhot,
Simone E Pitts,
Stacey S Degarmo,
Sukhanya Jayachandra,
Susan M Jackson,
Thomas Finn, PhD,
Victor J Gangi,
Walter Lange,
Wayne E Seifert,
Yanming An, PhD,
Zhihao Qiu (Peter), PhD
Ekaterina Allen's Documents
Publish Date | Document Type | Title |
---|---|---|
June, 2016 | FDA 483 | Protein Sciences Corporation - Form 483, 2016-06-15 |
July, 2021 | FDA 483 | Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - Form 483, 2021-07-23 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more